Verrica Pharmaceuticals I...

NASDAQ: VRCA · Real-Time Price · USD
6.15
-0.44 (-6.68%)
At close: Aug 14, 2025, 3:59 PM
6.03
-1.95%
After-hours: Aug 14, 2025, 05:12 PM EDT

Verrica Pharmaceuticals Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
7.57M 5.12M 9.03M 12M
Cost of Revenue
1.85M 746K 725K 472K
Gross Profit
5.71M 4.38M 8.31M 11.53M
Operating Income
-65.92M -65.76M -21.3M -30.91M
Interest Income
1.42M 2.74M 476K 123K
Pretax Income
-76.58M -67M -24.49M -35.08M
Net Income
-76.58M -67M -24.49M -35.08M
Selling & General & Admin
58.82M 47.3M 17.41M 26.98M
Research & Development
11.84M 20.3M 12.2M 15.93M
Other Expenses
970K 2.54M n/a -472K
Operating Expenses
71.63M 70.14M 29.6M 42.44M
Interest Expense
9.41M 3.96M 2.17M 4.29M
Selling & Marketing Expenses
4.3K 3.5K n/a n/a
Cost & Expenses
73.48M 70.88M 30.33M 42.91M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
5.18M 4.53M 3.42M 2.7M
Shares Outstanding (Diluted)
5.18M 4.53M 3.42M 2.7M
EPS (Basic)
-14.78 -14.78 -7.17 -12.97
EPS (Diluted)
-14.78 -14.78 -7.17 -12.97
EBITDA
-65.9M -62.2M -21.6M -30.31M
EBIT
-67.17M -63.03M -22.32M -30.79M
Depreciation & Amortization
1.27M 836K 718K 472K